Surgeon Gareth Honeybone wants wider access to zanidatamab to treat one of the deadliest cancers.

The anti-parasitic drug became a household name during the COVID-19 pandemic, and it is now being embraced as an alternative ...

Oldale, who was diagnosed with advanced cancer after experiencing pain in his shoulder in July 2024, said taking part in the ...

Individuals share their journeys battling cancer and their experiences with groundbreaking immunotherapy treatments.

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) ...

Cancer patients are giving up on the NHS and going private for chemotherapy in record numbers. Experts said desperate ...

The FDA has ordered MacroGenics to halt enrollment in a phase 2 trial of the biotech’s lead candidate lorigerlimab following severe side effects that led to one patient's death.

CURE spoke with incoming ASCO president Dr. Deb Schrag on elevating the patient voice, humanism in care and why partnership shapes better cancer outcomes. Dr. Deb Schrag knows all about the importance ...

Charly's dad says the public inquiry is not going to give patients and families the answers they are looking for.

As part of a year-long study at Vanderbilt Health, the head and neck cancer team teamed up with the school's 3D printing lab to print three-dimensional tumors for patients.

A former California executive was charged today and has agreed to plead guilty in connection with failing to file adverse event reports with the intent to defraud and mislead the Food and Drug ...